tiprankstipranks
Advertisement
Advertisement

NTRA Stock Latest News

IHI, IHE, ARKG: Specialty Healthcare ETFs Offer Diversification and Growth to Investors
Market NewsIHI, IHE, ARKG: Specialty Healthcare ETFs Offer Diversification and Growth to Investors
9d ago
BSX
IHE
Natera announces publications on clinical utility of Signatera
PremiumThe Fly
Natera announces publications on clinical utility of Signatera
12d ago
NTRA
GeneDx data could support improved coverage, says Craig-Hallum
PremiumThe Fly
GeneDx data could support improved coverage, says Craig-Hallum
16d ago
WGS
NTRA
Natera announces commercial launch of Zenith genomics
PremiumThe Fly
Natera announces commercial launch of Zenith genomics
16d ago
WGS
NTRA
GeneDx falls after Natera launches sequencing assay for rare diseases
PremiumThe Fly
GeneDx falls after Natera launches sequencing assay for rare diseases
16d ago
WGS
NTRA
IHI, IHE, ARKG: Specialty Healthcare ETFs Offer Portfolio Diversification to Investors
PremiumMarket NewsIHI, IHE, ARKG: Specialty Healthcare ETFs Offer Portfolio Diversification to Investors
17d ago
BSX
IHE
Natera Inc. Earnings Call Signals Profitable Growth
Premium
Company Announcements
Natera Inc. Earnings Call Signals Profitable Growth
22d ago
NTRA
Natera price target lowered to $250 from $265 at Morgan Stanley
Premium
The Fly
Natera price target lowered to $250 from $265 at Morgan Stanley
25d ago
NTRA
Maintained Buy on Natera: DCF‑Backed Upside and Attractive Long‑Term Growth Profile Despite Lower Price Target
PremiumRatings
Maintained Buy on Natera: DCF‑Backed Upside and Attractive Long‑Term Growth Profile Despite Lower Price Target
25d ago
NTRA
Natera: Strong Execution, Growing Signatera MRD Franchise, and Multiple Catalysts Support Buy Rating and $260 Target
PremiumRatings
Natera: Strong Execution, Growing Signatera MRD Franchise, and Multiple Catalysts Support Buy Rating and $260 Target
25d ago
NTRA
Natera: Sustained Outperformance, Conservative 2026 Guidance, and Innovation-Driven Upside Support Buy Rating and $285 Target
PremiumRatings
Natera: Sustained Outperformance, Conservative 2026 Guidance, and Innovation-Driven Upside Support Buy Rating and $285 Target
29d ago
NTRA
Natera to present new data in geniturinary malignancies at ASCO GU
PremiumThe Fly
Natera to present new data in geniturinary malignancies at ASCO GU
29d ago
NTRA
Natera price target raised to $260 from $250 at Evercore ISI
PremiumThe FlyNatera price target raised to $260 from $250 at Evercore ISI
29d ago
NTRA
Natera price target raised to $290 from $280 at UBS
Premium
The Fly
Natera price target raised to $290 from $280 at UBS
29d ago
NTRA
Natera price target raised to $215 from $205 at Wells Fargo
Premium
The Fly
Natera price target raised to $215 from $205 at Wells Fargo
29d ago
NTRA
Natera price target raised to $257 from $239 at Baird
PremiumThe Fly
Natera price target raised to $257 from $239 at Baird
29d ago
NTRA
Natera price target raised to $280 from $270 at Barclays
PremiumThe Fly
Natera price target raised to $280 from $270 at Barclays
29d ago
NTRA
Natera: Underpenetrated Growth, Emerging Catalysts, and a Clear Path to Cash Flow Support a Buy Rating
PremiumRatings
Natera: Underpenetrated Growth, Emerging Catalysts, and a Clear Path to Cash Flow Support a Buy Rating
29d ago
NTRA
Natera reports FY25 EPS ($1.52), consensus ($2.42)
PremiumThe Fly
Natera reports FY25 EPS ($1.52), consensus ($2.42)
29d ago
NTRA
Natera says Phase 2 SINERGY trial met primary endpoint
PremiumThe FlyNatera says Phase 2 SINERGY trial met primary endpoint
1M ago
NTRA
Natera Inc. (NTRA) Q4 Earnings Cheat Sheet
Premium
Pre-Earnings
Natera Inc. (NTRA) Q4 Earnings Cheat Sheet
1M ago
NTRA
IHI, IHE, ARKG: Specialty Healthcare ETFs Can Help Boost a Portfolio
Premium
Market News
IHI, IHE, ARKG: Specialty Healthcare ETFs Can Help Boost a Portfolio
1M ago
BSX
IHE

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >